Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002864179 | SCV003621886 | uncertain significance | Inborn genetic diseases | 2022-05-06 | criteria provided, single submitter | clinical testing | The c.85A>G (p.N29D) alteration is located in exon 2 (coding exon 2) of the ITGB3 gene. This alteration results from a A to G substitution at nucleotide position 85, causing the asparagine (N) at amino acid position 29 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005021708 | SCV005644191 | uncertain significance | Myocardial infarction, susceptibility to; Glanzmann thrombasthenia 2; Bleeding disorder, platelet-type, 24 | 2024-04-12 | criteria provided, single submitter | clinical testing |